Milestone Pharmaceuticals Inc. ( NASDAQ:MIST ) is possibly approaching a major achievement in its business, so we would... - PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray ...
Hosted on MSN6d
What pediatricians do when their own babies get sickStraight from the trenches of caring for their own babies and toddlers through cold and flu season, six pediatricians share ...
State of Alaska Department of Revenue lessened its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 1.6% in the fourth quarter, HoldingsChannel reports. The fund owned 21,325 ...
A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
Cognitive neuroscientist Eleanor Maguire, PhD, whose studies of London taxi drivers' brains helped transform memory research, ...
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal ...
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback